Determination of dexmedetomidine in rat plasma by a sensitive [H-3]clonidine radioreceptor assay

This paper describes the development and implementation of a sensitive radioreceptor assay (RRA) for determining concentrations of dexmedetomidine, an alpha-2 adrenergic agonist with anesthetic properties, in rat plasma, Calf retina membranes were selected as the alpha-2 adrenergic receptor source, and the alpha-2 antagonist [H-3]RX821002 and the alpha-2 agonist [H-3]clonidine were evaluated as radioligands. We optimized the binding conditions for both radioligands and chose a radioligand for implementation in the RRA based on the characteristics of the inhibition binding curves with dexmedetomidine. The final method is based on competition between the radioligand [H-3]clonidine and dexmedetomidine for high-affinity binding sites present in calf retina membranes. The assay has a coefficient of variation of 8% in the range 23.7-592 pg for 0.2 mL of plasma, This assay can be applied to pharmacokinetic-pharmacodynamic studies of dexmedetomidine.